Malaysian Genomics Resource Centre Berhad is partnering with Innoquest Pathology Sdn Bhd, the largest provider of laboratory services in Malaysia with the aim of procuring and marketing its genetic screening services.
Noor Azri Dato’ Sri Noor Azerai, Executive Chairman of MGRC said he anticipates a synergistic collaboration with Innoquest in expanding the presence of genetic screening services and products covering Dtect, Origene and Origene with Pharmacogenomics (PGx) screening methodology in the market at large in the future.
In line with the partnership MGRC will give Innoquest access to its genetic screening services to be made available to its network of healthcare providers throughout Malaysia which includes more than 200 hospitals and 5,000 clinicAccording to Adam Hathsey, Innoquest’s Deputy CEO for West Malaysia, these genetic screening provides insights to patients’ genetic make-up and help assess their potential risks and predisposition to certain diseases. This also helps patients to be more aware in managing their lifestyle choices and in planning their regular health screening according to their individual risk factors.
